Filing Details
- Accession Number:
- 0001601364-15-000002
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-01-26 17:31:29
- Reporting Period:
- 2015-01-22
- Filing Date:
- 2015-01-26
- Accepted Time:
- 2015-01-26 17:31:29
- Original Submission Date:
- 2015-01-26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513818 | Versartis Inc. | VSAR | Pharmaceutical Preparations (2834) | 244106690 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601363 | Advent Life Sciences Fund I Lp | 158 North Gower Street London X0 NW1 2ND | No | No | No | Yes | |
| 1601364 | Llp Sciences Life Advent | 158 North Gower Street London X0 NW1 2ND | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-22 | 55,000 | $17.25 | 2,271,558 | No | 4 | P | Indirect | See FN |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See FN |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | $21.00 | 2024-03-19 | 35,000 | 35,000 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-03-19 | 35,000 | 35,000 | Indirect |
Footnotes
- Securities are held by Advent Life Sciences LLP ("Advent") and Advent Life Sciences Fund I LP ("Advent Fund"). Advent is the general partner of Advent Fund. Advent disclaims beneficial ownership of the shares held by Advent Fund except to the extent of its indirect pecuniary interest therein. Shahzad Malik, an affiliate of the Reporting Persons, is a member of the Issuer's board of directors, and disclaims beneficial ownership of the shares held by Advent or the Advent Fund except to the extent of his indirect pecuniary interest therein.
- One-fourth of the total number of shares subject to the option shall vest and become exercisable one year from 3/21/2014 (the "Vesting Commencement Date") and 1/36th of the remaining number of shares subject to the option shall vest and become exercisable on each monthly anniversary of the Vesting Commencement Date thereafter.
- Securities are held by Shahzad Malik, an affiliate of the Reporting Persons. The Reporting Persons disclaim beneficial ownership of the securities held by Shahzad Malik.
Billionaire Hedge Funds
